HPR18 What Is the Impact of Including Outcomes-Based Agreements on the Cost-Effectiveness of Cell and Gene Therapies? A Case Example of Zynteglo for Transfusion-Dependent Beta Thalassemia
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1088
https://www.valueinhealthjournal.com/article/S1098-3015(24)01203-8/fulltext
Title :
HPR18 What Is the Impact of Including Outcomes-Based Agreements on the Cost-Effectiveness of Cell and Gene Therapies? A Case Example of Zynteglo for Transfusion-Dependent Beta Thalassemia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01203-8&doi=10.1016/j.jval.2024.03.1088
First page :
Section Title :
Open access? :
No
Section Order :
10505